【ABC-KY】Monthly Revenue for May 2026: NT$0.60 Billion (YoY +134.9%)

Company Code: 6598 Company Name: ABC-KY Industry: Biotechnology and Healthcare Reporting Month: May 2026 Monthly Revenue: NT$60,307 thousand (approximately NT$603.07 million) Year-on-Year Change: +134.9%

ABC-KY has released its monthly revenue report for May 2026, recording NT$60,307 thousand (about NT$603.07 million), a substantial 134.9% increase compared to NT$25,678 thousand in the same month of the previous year. This remarkable growth is attributed to rising demand for the company's biopharmaceuticals and diagnostic technologies, successful market entry into new regions, and the positive outcomes of strategic partnerships.

Amid ongoing expansion in the biotech and healthcare industry, ABC-KY continues to invest heavily in research and development, focusing on next-generation therapies and AI-integrated medical solutions. The current revenue surge indicates that the company's long-term strategies are beginning to yield tangible financial results, boosting market confidence in its future performance.

Looking ahead, ABC-KY plans to strengthen its presence in Asian and Western markets by expanding its product portfolio to meet global healthcare demands. The company's continued growth trajectory in the upcoming fiscal period is drawing significant attention from investors and industry observers alike.